Sex differences and central protective effect of 17β-estradiol in the development of aldosterone/NaCl-induced hypertension

Baojian Xue, Daniel Badaue-Passos, Fang Guo, Celso E. Gomez-Sanchez, Meredith Hay, Alan Kim Johnson

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The present study tested the hypotheses that male and female rats respond differently to subcutaneous infusions of aldosterone (Aldo; 1.8 μg·kg-1·h-1, 1% NaCl to drink; 28 days) and that central estrogen plays a protective role against the development of hypertension. In rats with blood pressure (BP) and heart rate (HR) measured by Data Sciences International telemetry, chronic Aldo/NaCl treatment induced a greater increase in BP in males (Δ25.4 ± 2.4 mmHg) than in females (Δ7.1 ± 2.2 mmHg). Gonadectomy augmented Aldo/NaCl-induced hypertension in females (Δ18.2 ± 2.0 mmHg) but had no effect in males (Δ23.1 ± 2.9 mmHg). Immunohistochemistry for Fra-like activity was higher in the paraventricular nucleus of intact males, castrated males, and ovariectomized (OVX) females compared with intact females after 28 days of Aldo/NaCl treatment. In intact males, central 17β-estradiol (E 2) inhibited the Aldo/NaCl increase in BP (Δ10.5 ± 0.8) compared with that in central vehicle plus systemic Aldo/NaCl (Δ26.1 ± 2.5 mmHg) rats. Combined administration of E2 and estrogen receptor antagonist ICI182780 (ICI) blocked the protective effect of E 2 (Δ23.2 ± 2.4 mmHg). In intact females central, but not peripheral, infusions of ICI augmented the Aldo/NaCl (Δ20.4 ± 1.8 mmHg) BP increase. Finally, ganglionic blockade after Aldo infusions resulted in a smaller reduction in BP in intact females (-23.9 ± 2.5 mmHg) and in central estrogen-treated males (-30.2 ± 1.0 mmHg) compared with other groups (intact males, -39.3 ± 3.4; castrated males, -41.8 ± 1.9; intact males with central E2 + ICI, -42.3 ± 2.1; OVX females, -40.3 ± 3.3; and intact females with central ICI, -39.1 ± 1.3 mmHg). Chronic Aldo infusion produced increases in NaCl intake and decreases in HR that were both similar in all groups. Taken together, the results indicate that central estrogen plays a protective role in the development of Aldo/NaCl-induced hypertension and that this may result from reduced sympathetic outflow.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume296
Issue number5
DOIs
StatePublished - May 2009

Fingerprint

Aldosterone
Sex Characteristics
Estradiol
Hypertension
Blood Pressure
Estrogens
Heart Rate
Subcutaneous Infusions
Telemetry
Paraventricular Hypothalamic Nucleus
Immunohistochemistry
Therapeutics

Keywords

  • Blood pressure
  • Estrogen receptor
  • Heart rate
  • Sympathetic nervous system

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Sex differences and central protective effect of 17β-estradiol in the development of aldosterone/NaCl-induced hypertension. / Xue, Baojian; Badaue-Passos, Daniel; Guo, Fang; Gomez-Sanchez, Celso E.; Hay, Meredith; Johnson, Alan Kim.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 296, No. 5, 05.2009.

Research output: Contribution to journalArticle

@article{44ea96917ca2443fada532f9d2925c57,
title = "Sex differences and central protective effect of 17β-estradiol in the development of aldosterone/NaCl-induced hypertension",
abstract = "The present study tested the hypotheses that male and female rats respond differently to subcutaneous infusions of aldosterone (Aldo; 1.8 μg·kg-1·h-1, 1{\%} NaCl to drink; 28 days) and that central estrogen plays a protective role against the development of hypertension. In rats with blood pressure (BP) and heart rate (HR) measured by Data Sciences International telemetry, chronic Aldo/NaCl treatment induced a greater increase in BP in males (Δ25.4 ± 2.4 mmHg) than in females (Δ7.1 ± 2.2 mmHg). Gonadectomy augmented Aldo/NaCl-induced hypertension in females (Δ18.2 ± 2.0 mmHg) but had no effect in males (Δ23.1 ± 2.9 mmHg). Immunohistochemistry for Fra-like activity was higher in the paraventricular nucleus of intact males, castrated males, and ovariectomized (OVX) females compared with intact females after 28 days of Aldo/NaCl treatment. In intact males, central 17β-estradiol (E 2) inhibited the Aldo/NaCl increase in BP (Δ10.5 ± 0.8) compared with that in central vehicle plus systemic Aldo/NaCl (Δ26.1 ± 2.5 mmHg) rats. Combined administration of E2 and estrogen receptor antagonist ICI182780 (ICI) blocked the protective effect of E 2 (Δ23.2 ± 2.4 mmHg). In intact females central, but not peripheral, infusions of ICI augmented the Aldo/NaCl (Δ20.4 ± 1.8 mmHg) BP increase. Finally, ganglionic blockade after Aldo infusions resulted in a smaller reduction in BP in intact females (-23.9 ± 2.5 mmHg) and in central estrogen-treated males (-30.2 ± 1.0 mmHg) compared with other groups (intact males, -39.3 ± 3.4; castrated males, -41.8 ± 1.9; intact males with central E2 + ICI, -42.3 ± 2.1; OVX females, -40.3 ± 3.3; and intact females with central ICI, -39.1 ± 1.3 mmHg). Chronic Aldo infusion produced increases in NaCl intake and decreases in HR that were both similar in all groups. Taken together, the results indicate that central estrogen plays a protective role in the development of Aldo/NaCl-induced hypertension and that this may result from reduced sympathetic outflow.",
keywords = "Blood pressure, Estrogen receptor, Heart rate, Sympathetic nervous system",
author = "Baojian Xue and Daniel Badaue-Passos and Fang Guo and Gomez-Sanchez, {Celso E.} and Meredith Hay and Johnson, {Alan Kim}",
year = "2009",
month = "5",
doi = "10.1152/ajpheart.01255.2008",
language = "English (US)",
volume = "296",
journal = "American Journal of Physiology",
issn = "0363-6143",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - Sex differences and central protective effect of 17β-estradiol in the development of aldosterone/NaCl-induced hypertension

AU - Xue, Baojian

AU - Badaue-Passos, Daniel

AU - Guo, Fang

AU - Gomez-Sanchez, Celso E.

AU - Hay, Meredith

AU - Johnson, Alan Kim

PY - 2009/5

Y1 - 2009/5

N2 - The present study tested the hypotheses that male and female rats respond differently to subcutaneous infusions of aldosterone (Aldo; 1.8 μg·kg-1·h-1, 1% NaCl to drink; 28 days) and that central estrogen plays a protective role against the development of hypertension. In rats with blood pressure (BP) and heart rate (HR) measured by Data Sciences International telemetry, chronic Aldo/NaCl treatment induced a greater increase in BP in males (Δ25.4 ± 2.4 mmHg) than in females (Δ7.1 ± 2.2 mmHg). Gonadectomy augmented Aldo/NaCl-induced hypertension in females (Δ18.2 ± 2.0 mmHg) but had no effect in males (Δ23.1 ± 2.9 mmHg). Immunohistochemistry for Fra-like activity was higher in the paraventricular nucleus of intact males, castrated males, and ovariectomized (OVX) females compared with intact females after 28 days of Aldo/NaCl treatment. In intact males, central 17β-estradiol (E 2) inhibited the Aldo/NaCl increase in BP (Δ10.5 ± 0.8) compared with that in central vehicle plus systemic Aldo/NaCl (Δ26.1 ± 2.5 mmHg) rats. Combined administration of E2 and estrogen receptor antagonist ICI182780 (ICI) blocked the protective effect of E 2 (Δ23.2 ± 2.4 mmHg). In intact females central, but not peripheral, infusions of ICI augmented the Aldo/NaCl (Δ20.4 ± 1.8 mmHg) BP increase. Finally, ganglionic blockade after Aldo infusions resulted in a smaller reduction in BP in intact females (-23.9 ± 2.5 mmHg) and in central estrogen-treated males (-30.2 ± 1.0 mmHg) compared with other groups (intact males, -39.3 ± 3.4; castrated males, -41.8 ± 1.9; intact males with central E2 + ICI, -42.3 ± 2.1; OVX females, -40.3 ± 3.3; and intact females with central ICI, -39.1 ± 1.3 mmHg). Chronic Aldo infusion produced increases in NaCl intake and decreases in HR that were both similar in all groups. Taken together, the results indicate that central estrogen plays a protective role in the development of Aldo/NaCl-induced hypertension and that this may result from reduced sympathetic outflow.

AB - The present study tested the hypotheses that male and female rats respond differently to subcutaneous infusions of aldosterone (Aldo; 1.8 μg·kg-1·h-1, 1% NaCl to drink; 28 days) and that central estrogen plays a protective role against the development of hypertension. In rats with blood pressure (BP) and heart rate (HR) measured by Data Sciences International telemetry, chronic Aldo/NaCl treatment induced a greater increase in BP in males (Δ25.4 ± 2.4 mmHg) than in females (Δ7.1 ± 2.2 mmHg). Gonadectomy augmented Aldo/NaCl-induced hypertension in females (Δ18.2 ± 2.0 mmHg) but had no effect in males (Δ23.1 ± 2.9 mmHg). Immunohistochemistry for Fra-like activity was higher in the paraventricular nucleus of intact males, castrated males, and ovariectomized (OVX) females compared with intact females after 28 days of Aldo/NaCl treatment. In intact males, central 17β-estradiol (E 2) inhibited the Aldo/NaCl increase in BP (Δ10.5 ± 0.8) compared with that in central vehicle plus systemic Aldo/NaCl (Δ26.1 ± 2.5 mmHg) rats. Combined administration of E2 and estrogen receptor antagonist ICI182780 (ICI) blocked the protective effect of E 2 (Δ23.2 ± 2.4 mmHg). In intact females central, but not peripheral, infusions of ICI augmented the Aldo/NaCl (Δ20.4 ± 1.8 mmHg) BP increase. Finally, ganglionic blockade after Aldo infusions resulted in a smaller reduction in BP in intact females (-23.9 ± 2.5 mmHg) and in central estrogen-treated males (-30.2 ± 1.0 mmHg) compared with other groups (intact males, -39.3 ± 3.4; castrated males, -41.8 ± 1.9; intact males with central E2 + ICI, -42.3 ± 2.1; OVX females, -40.3 ± 3.3; and intact females with central ICI, -39.1 ± 1.3 mmHg). Chronic Aldo infusion produced increases in NaCl intake and decreases in HR that were both similar in all groups. Taken together, the results indicate that central estrogen plays a protective role in the development of Aldo/NaCl-induced hypertension and that this may result from reduced sympathetic outflow.

KW - Blood pressure

KW - Estrogen receptor

KW - Heart rate

KW - Sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=66149149718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149149718&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.01255.2008

DO - 10.1152/ajpheart.01255.2008

M3 - Article

C2 - 19270192

AN - SCOPUS:66149149718

VL - 296

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6143

IS - 5

ER -